GCK and Hyperglycemia: The hexokinase inhibitor D-Mannoheptulose has been shown to prevent damaging effects of hyperglycemia in β-cells and islets in vitro14; however beneficial effects of glucokinase inhibitors (GKI) on whole diabetic organisms have not been confirmed.